2841 related articles for article (PubMed ID: 20164920)
1. The landscape of somatic copy-number alteration across human cancers.
Beroukhim R; Mermel CH; Porter D; Wei G; Raychaudhuri S; Donovan J; Barretina J; Boehm JS; Dobson J; Urashima M; Mc Henry KT; Pinchback RM; Ligon AH; Cho YJ; Haery L; Greulich H; Reich M; Winckler W; Lawrence MS; Weir BA; Tanaka KE; Chiang DY; Bass AJ; Loo A; Hoffman C; Prensner J; Liefeld T; Gao Q; Yecies D; Signoretti S; Maher E; Kaye FJ; Sasaki H; Tepper JE; Fletcher JA; Tabernero J; Baselga J; Tsao MS; Demichelis F; Rubin MA; Janne PA; Daly MJ; Nucera C; Levine RL; Ebert BL; Gabriel S; Rustgi AK; Antonescu CR; Ladanyi M; Letai A; Garraway LA; Loda M; Beer DG; True LD; Okamoto A; Pomeroy SL; Singer S; Golub TR; Lander ES; Getz G; Sellers WR; Meyerson M
Nature; 2010 Feb; 463(7283):899-905. PubMed ID: 20164920
[TBL] [Abstract][Full Text] [Related]
2. Genomic analysis and selective small molecule inhibition identifies BCL-X(L) as a critical survival factor in a subset of colorectal cancer.
Zhang H; Xue J; Hessler P; Tahir SK; Chen J; Jin S; Souers AJ; Leverson JD; Lam LT
Mol Cancer; 2015 Jul; 14():126. PubMed ID: 26134786
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer sub-types display heterogeneity in gene amplification and mRNA expression of the anti-apoptotic members of BCL2 family.
Voutsadakis IA
Gene; 2023 Mar; 857():147179. PubMed ID: 36627096
[TBL] [Abstract][Full Text] [Related]
4. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
Chen Y; Sadasivan SM; She R; Datta I; Taneja K; Chitale D; Gupta N; Davis MB; Newman LA; Rogers CG; Paris PL; Li J; Rybicki BA; Levin AM
BMC Med Genomics; 2020 Aug; 13(1):116. PubMed ID: 32819446
[TBL] [Abstract][Full Text] [Related]
5. Genomic determinants of somatic copy number alterations across human cancers.
Zhang Y; Xu H; Frishman D
Hum Mol Genet; 2016 Mar; 25(5):1019-30. PubMed ID: 26732428
[TBL] [Abstract][Full Text] [Related]
6. Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL Blockade.
Williams MM; Lee L; Hicks DJ; Joly MM; Elion D; Rahman B; McKernan C; Sanchez V; Balko JM; Stricker T; Estrada MV; Cook RS
Mol Cancer Res; 2017 Mar; 15(3):259-268. PubMed ID: 28039357
[TBL] [Abstract][Full Text] [Related]
7. Pan-cancer patterns of somatic copy number alteration.
Zack TI; Schumacher SE; Carter SL; Cherniack AD; Saksena G; Tabak B; Lawrence MS; Zhsng CZ; Wala J; Mermel CH; Sougnez C; Gabriel SB; Hernandez B; Shen H; Laird PW; Getz G; Meyerson M; Beroukhim R
Nat Genet; 2013 Oct; 45(10):1134-40. PubMed ID: 24071852
[TBL] [Abstract][Full Text] [Related]
8. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers.
Mermel CH; Schumacher SE; Hill B; Meyerson ML; Beroukhim R; Getz G
Genome Biol; 2011; 12(4):R41. PubMed ID: 21527027
[TBL] [Abstract][Full Text] [Related]
9. Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer.
Park H; Cho SY; Kim H; Na D; Han JY; Chae J; Park C; Park OK; Min S; Kang J; Choi B; Min J; Kwon JY; Suh YS; Kong SH; Lee HJ; Liu ET; Kim JI; Kim S; Yang HK; Lee C
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12492-7. PubMed ID: 26401016
[TBL] [Abstract][Full Text] [Related]
10. Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression.
Roszik J; Wu CJ; Siroy AE; Lazar AJ; Davies MA; Woodman SE; Kwong LN
Sci Rep; 2016 Jan; 6():19649. PubMed ID: 26787600
[TBL] [Abstract][Full Text] [Related]
11. Low-cost and clinically applicable copy number profiling using repeat DNA.
Abujudeh S; Zeki SS; van Lanschot MCJ; Pusung M; Weaver JMJ; Li X; Noorani A; Metz AJ; Bornschein J; Bower L; Miremadi A; Fitzgerald RC; Morrissey ER; Lynch AG
BMC Genomics; 2022 Aug; 23(1):599. PubMed ID: 35978291
[TBL] [Abstract][Full Text] [Related]
12. Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian Cancer.
Stover EH; Baco MB; Cohen O; Li YY; Christie EL; Bagul M; Goodale A; Lee Y; Pantel S; Rees MG; Wei G; Presser AG; Gelbard MK; Zhang W; Zervantonakis IK; Bhola PD; Ryan J; Guerriero JL; Montero J; Liang FJ; Cherniack AD; Piccioni F; Matulonis UA; Bowtell DDL; Sarosiek KA; Letai A; Garraway LA; Johannessen CM; Meyerson M
Mol Cancer Res; 2019 Nov; 17(11):2281-2293. PubMed ID: 31462500
[TBL] [Abstract][Full Text] [Related]
13. A systematic comparison of copy number alterations in four types of female cancer.
Kaveh F; Baumbusch LO; Nebdal D; Børresen-Dale AL; Lingjærde OC; Edvardsen H; Kristensen VN; Solvang HK
BMC Cancer; 2016 Nov; 16(1):913. PubMed ID: 27876019
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal instability selects gene copy-number variants encoding core regulators of proliferation in ER+ breast cancer.
Endesfelder D; Burrell R; Kanu N; McGranahan N; Howell M; Parker PJ; Downward J; Swanton C; Kschischo M
Cancer Res; 2014 Sep; 74(17):4853-4863. PubMed ID: 24970479
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of methods for identifying somatic copy number alterations from deep sequencing data.
Alkodsi A; Louhimo R; Hautaniemi S
Brief Bioinform; 2015 Mar; 16(2):242-54. PubMed ID: 24599115
[TBL] [Abstract][Full Text] [Related]
16. Gene expression analysis identifies global gene dosage sensitivity in cancer.
Fehrmann RS; Karjalainen JM; Krajewska M; Westra HJ; Maloney D; Simeonov A; Pers TH; Hirschhorn JN; Jansen RC; Schultes EA; van Haagen HH; de Vries EG; te Meerman GJ; Wijmenga C; van Vugt MA; Franke L
Nat Genet; 2015 Feb; 47(2):115-25. PubMed ID: 25581432
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of somatic copy-number alterations across different human cancer types reveals two distinct classes of breakpoint hotspots.
Li Y; Zhang L; Ball RL; Liang X; Li J; Lin Z; Liang H
Hum Mol Genet; 2012 Nov; 21(22):4957-65. PubMed ID: 22899649
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting the expression of anti-apoptotic genes BCL2L1 and MCL1, and apoptosis induction in glioblastoma cells by microRNA-342.
Ghaemi S; Arefian E; Rezazadeh Valojerdi R; Soleimani M; Moradimotlagh A; Jamshidi Adegani F
Biomed Pharmacother; 2020 Jan; 121():109641. PubMed ID: 31751869
[TBL] [Abstract][Full Text] [Related]
19. Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis.
Wang G; Anastassiou D
Sci Rep; 2020 Oct; 10(1):17199. PubMed ID: 33057153
[TBL] [Abstract][Full Text] [Related]
20. Copy-number variation of MCL1 predicts overall survival of non-small-cell lung cancer in a Southern Chinese population.
Yin J; Li Y; Zhao H; Qin Q; Li X; Huang J; Shi Y; Gong S; Liu L; Fu X; Nie S; Wei S
Cancer Med; 2016 Sep; 5(9):2171-9. PubMed ID: 27264345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
